 |
Research to Reality:
Human-Centered Approaches to Recruitment and Retention
Presented by Lisa Marceau, MPH, PMP & Julia Coleman, BA [Anthem/HealthCore (formerly NERI)]
The goal of this series is to provide an understanding of the ethical background,
regulatory knowledge, and models of best practices for conducting research when the participants represent special populations and vulnerable subjects.
|
|
|
|
|
New Funding Opportunities |
|
|
|
|
Notice of Special Interest (NOSI): Leveraging transformative connectome resources in model organisms to elucidate the neurobiology of substance use disorders
Notice of Special Interest (NOSI): Leveraging Longitudinal Studies
in Animal Models to Identify Neural Mechanisms of Vulnerability and Resilience to Substance Use Disorder
National Institute on Drug Abuse (NIDA)
|
Notice of Special Interest (NOSI): Reproductive Health, Pregnancy, and Parenting among Women with Disabilities
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
|
|
|
|
Translational Neural Devices (U44 Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke (NINDS)
|
Notice of Special Interest (NOSI): Expanding Cancer Control Research in Persistent Poverty Areas
National Cancer Institute (NCI)
|
Pediatric and Perinatal COVID-19 Registry (U18) Clinical Trials Optional
U.S. Food and Drug Administration (FDA)
|
Special Emphasis Notice (SEN): AHRQ Announces Interest in Health Services Research to Advance Health Equity
Agency for Healthcare Research and Quality (AHRQ)
|
|
|
|
Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R41/R42 Clinical Trial Not Allowed)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP)
|
Resource Center for the Support for Research Excellence (SuRE) Program (U24 - Clinical Trial Not Allowed)
National Institute of General Medical Sciences (NIGMS)
|
Addressing Social Determinants of Health to Eliminate Oral Health Disparities (UG3/UH3 Clinical Trials Optional)
National Institute of Dental and Craniofacial Research (NIDCR)
|
|
|
|
|
Application Deadline: May 15, 2021
BU Biomedical Engineering and
the BU Clinical and Translational Science Institute are pleased to announce a renewed phase of our collaborative program, the Bridge BUilders Initiative.
The Initiative is designed
to accelerate the development of clinician-inspired medical device innovations by partnering with a team with expertise in engineering design and product development.
|
|
|
|
Application Deadline: Jun. 7, 2021
The Boston University Digital Health Initiative (DHI) is pleased to award funding to BU faculty conducting transdisciplinary research that seeks novel digital solutions to modern healthcare’s greatest challenges.
This year, we are focusing on
the translation of basic science discoveries into mobile and electronic interventions and the development and testing of mobile health devices, methodologies
|
|
|
|
|
NIH to Invest $29 Million to Address
COVID-19 Disparities
“The goal of this effort is to foster community-engagement research in communities which have been hit hardest by the pandemic,” said Gary H. Gibbons, M.D., director, National Heart, Lung, and Blood Institute (NHLBI). Read More
|
|
|
|
|
SARS-CoV-2 Seropositivity and Subsequent Infection Risk in Healthy Young Adults: a Prospective Cohort Study
This analysis was performed as part of the prospective COVID-19 Health Action Response for Marines study (CHARM). CHARM included predominantly male US Marine recruits, aged 18–20 years, following a 2-week unsupervised quarantine at home. Read More
|
|
|
|
|
Tracking the Evolution of a ‘Variant of Concern’ in Brazil
Despite hopes of achieving “herd immunity” in this city of 2.2 million in the Amazon region, the virus came roaring back in late 2020 and early 2021 to cause a second wave of illness and death. How is this possible? Read More
|
|
|
|
|
New N3C Learning and Discussion Opportunity: The Enclave Users’ Group
May. 7, 2021, 2 p.m.
This webinar will demonstrate the logic needed to identify patients as “COVID-positive” at first diagnosis and the identification method that was used. Read More
|
|
|
|
|
NIH HEAL Initiative Investigator Meeting
May 17, 2021, 10 a.m.
This meeting will bring together more than 500 NIH HEAL Initiative awardees, federal officials, people with lived experience, and other stakeholders to share research breakthroughs, highlight cutting-edge science, explore shared interests, and identify opportunities to advance the goals of the NIH HEAL Initiative. Read More
|
|
|
|
|
Understanding Medical Device and Diagnostic Development Processes and Contemporary Realities
May 26 - Jun.23 , 2021, 12 p.m.
The five sessions will cover the fundamentals of the device and diagnostic development presented through the lens of challenges posed by the COVID-19 pandemic. Read More
|
|
|
|
|
The Funding Acknowledgement |
|
|
|
|
The Funding Acknowledgement guides recipients of BU CTSI services, resources, or funding for projects or research through the grant citation process. All recipients are required to cite our grant number in associated presentations and journal publications.
|
|
|
|
|
|
|
|
|
